Skip to main content
Watch Insiders
UPBHealthcare

Upstream Bio Inc. (UPB) Insider Trading

In the last 90 days, 5 Upstream Bio Inc. (UPB) insiders reported no open-market purchases and 5 sales totaling $27,604. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 16, 2026Aaron DeykinChief Medical OfficerSale895$5.49$4,914
Sep 16, 2026Everett Rand SutherlandChief Executive OfficerSale2,095$5.49$11,502
Sep 16, 2026Adam HoughtonChief Business OfficerSale700$5.49$3,843
Sep 16, 2026Michael GrayCFO and COOSale853$5.49$4,683
Sep 16, 2026Allison AmbroseGeneral CounselSale485$5.49$2,663
Jun 16, 2026Michael GrayCFO and COOSale853$6.10$5,203
Jun 16, 2026Everett Rand SutherlandChief Executive OfficerSale2,095$6.10$12,780
Jun 16, 2026Adam HoughtonChief Business OfficerSale700$6.10$4,270
Jun 16, 2026Aaron DeykinChief Medical OfficerSale895$6.10$5,460
Jun 16, 2026Allison AmbroseGeneral CounselSale477$6.10$2,910

Common questions

UPB insider trading FAQ

Are UPB insiders buying or selling?
Over the last 90 days, UPB insiders were net sellers, reporting $0.00 of open-market purchases and $27,604 of sales.
When was the last UPB insider purchase?
No open-market insider purchase of Upstream Bio Inc. stock was reported in the last 90 days.
Where does UPB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Upstream Bio Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.